Xenon Pharmaceuticals

Recent news

• Rating change
  A Quick Look at Today's Ratings for Xenon Pharmaceuticals(XENE.US), With a Forecast Between $74 to $80.65
  Market Newswire · 2026/5/8
• Rating change
  Stifel Maintains Xenon Pharmaceuticals(XENE.US) With Buy Rating, Maintains Target Price $89
  Market Newswire · 2026/4/28
• Rating change
  A Quick Look at Today's Ratings for Xenon Pharmaceuticals(XENE.US), With a Forecast Between $63 to $80.65
  Market Newswire · 2026/5/9
• Rating change
  Wedbush Maintains Xenon Pharmaceuticals(XENE.US) With Buy Rating, Cuts Target Price to $63
  Market Newswire · 2026/3/16
• Rating change
  J.P. Morgan Maintains Xenon Pharmaceuticals(XENE.US) With Buy Rating, Raises Target Price to $82
  Market Newswire · 2026/5/27
• Wells Fargo Maintains Xenon Pharmaceuticals(XENE.US) With Buy Rating, Maintains Target Price $69
  Market Newswire · 2026/9/10
• A Quick Look at Today's Ratings for Xenon Pharmaceuticals(XENE.US), With a Forecast Between $60 to $90
  Market Newswire · 2026/9/19
• Rating change
  J.P. Morgan Maintains Xenon Pharmaceuticals(XENE.US) With Buy Rating, Raises Target Price to $80
  Market Newswire · 2026/5/12
• Rating change
  A Quick Look at Today's Ratings for Xenon Pharmaceuticals(XENE.US), With a Forecast Between $81 to $90
  Market Newswire · 2026/8/7
• RBC Capital Maintains Xenon Pharmaceuticals(XENE.US) With Buy Rating, Maintains Target Price $70
  Market Newswire · 2026/10/1
• Rating change
  H.C. Wainwright Maintains Xenon Pharmaceuticals(XENE.US) With Buy Rating, Maintains Target Price $74
  Market Newswire · 2026/8/10
• Bloom Burton Maintains Xenon Pharmaceuticals(XENE.US) With Buy Rating, Cuts Target Price to $71
  Market Newswire · 2026/9/22
• Stifel Maintains Xenon Pharmaceuticals(XENE.US) With Buy Rating, Maintains Target Price $86
  Market Newswire · 2026/8/14
• Rating change
  Analysts Offer Insights on Healthcare Companies: Intensity Therapeutics, Inc. (INTS), IQVIA Holdings (IQV) and Xenon (XENE)
  TipRanks · 2026/3/30
• Rating change
  J.P. Morgan Remains a Buy on Xenon (XENE)
  TipRanks · 2026/8/11
• Rating change
  William Blair Maintains Xenon Pharmaceuticals(XENE.US) With Buy Rating
  Market Newswire · 2026/4/21
• Rating change
  H.C. Wainwright Remains a Buy on Xenon (XENE)
  TipRanks · 2026/5/8
• Rating change
  A Quick Look at Today's Ratings for Xenon Pharmaceuticals(XENE.US), With a Forecast Between $74 to $86
  Market Newswire · 2026/8/8
• Rating change
  J.P. Morgan Maintains Xenon Pharmaceuticals(XENE.US) With Buy Rating, Maintains Target Price $82
  Market Newswire · 2026/8/11
• Rating change
  Needham Maintains Xenon Pharmaceuticals(XENE.US) With Buy Rating, Maintains Target Price $80
  Market Newswire · 2026/4/21

Headlines are aggregated automatically and are not independently verified or edited by our team.